Neuronetics Inc. (NASDAQ:STIM) is one of the best-performing NASDAQ stocks according to analysts. On June 10, Neuronetics announced its significant presence at the 13th Annual Clinical TMS ...
Neuronetics, Inc., a medical technology company focused on mental health, has announced key updates regarding its NeuroStar therapy. The company will be a Silver Sponsor at the 13th Annual Clinical ...
MALVERN. Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming ...
Hosted on MSN
Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced new real-world data demonstrating that its NeuroStar transcranial magnetic stimulation (TMS) therapy delivers meaningful improvement in ...
MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the ...
Hosted on MSN
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) revealed a significant development in mental healthcare, announcing that Evernorth Health Services, a subsidiary of The Cigna Group, has expanded its ...
MALVERN, Pa., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results